{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:56:07Z","timestamp":1793332567966,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41366-025-02002-1","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T18:39:37Z","timestamp":1767638377000},"page":"988-996","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mental health outcomes in obesity interventions with GLP-1 receptor agonists: is it similar to other obesity interventions? A narrative review with systematic evidence synthesis"],"prefix":"10.1038","volume":"50","author":[{"given":"Darin","family":"Osborne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7909-3603","authenticated-orcid":false,"given":"Elamin","family":"Abdelgadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"2002_CR1","doi-asserted-by":"publisher","unstructured":"NMarlin SS, GBD 2016 SDG Collaborators. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet. 2017;390:2642\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(17)32336-X.","DOI":"10.1016\/S0140-6736(17)32336-X"},{"key":"2002_CR2","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"CJL Murray","year":"2020","unstructured":"Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396:1223\u201349.","journal-title":"Lancet"},{"key":"2002_CR3","doi-asserted-by":"publisher","first-page":"e009773","DOI":"10.1136\/bmjgh-2022-009773","volume":"7","author":"A Okunogbe","year":"2022","unstructured":"Okunogbe A, Nugent R, Spencer G, Powis J, Ralston J, Wilding J. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob Health. 2022;7:e009773.","journal-title":"BMJ Glob Health"},{"key":"2002_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4103\/jpgm.JPGM_712_16","volume":"63","author":"TM Rajan","year":"2017","unstructured":"Rajan TM, Menon V. Psychiatric disorders and obesity: a review of association studies. J Postgrad Med. 2017;63:182\u201390. https:\/\/doi.org\/10.4103\/jpgm.JPGM_712_16.","journal-title":"J Postgrad Med"},{"key":"2002_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s13679-015-0164-9","volume":"4","author":"C Avila","year":"2015","unstructured":"Avila C, Holloway AC, Hahn MK, Morrison KM, Restivo M, Anglin R, et al. An overview of links between obesity and mental health. Curr Obes Rep. 2015;4:303\u201310. https:\/\/doi.org\/10.1007\/s13679-015-0164-9.","journal-title":"Curr Obes Rep"},{"key":"2002_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/sj.ijo.0803701","volume":"32","author":"KM Scott","year":"2008","unstructured":"Scott KM, Bruffaerts R, Simon GE, Alonso J, Angermeyer M, de Girolamo G, et al. Obesity and mental disorders in the general population: results from the world mental health surveys. Int J Obes. 2008;32:192\u2013200. https:\/\/doi.org\/10.1038\/sj.ijo.0803701.","journal-title":"Int J Obes"},{"key":"2002_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","volume":"67","author":"FS Luppino","year":"2010","unstructured":"Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67:220\u20139. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2010.2.","journal-title":"Arch Gen Psychiatry"},{"key":"2002_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.diabet.2010.08.004","volume":"36","author":"H Mosnier-Pudar","year":"2010","unstructured":"Mosnier-Pudar H, Hochberg G, Eschwege E, Halimi S, Virally ML, Guillausseau PJ, et al. How patients\u2019 attitudes and opinions influence self-care behaviours in type 2 diabetes. Insights from the French DIABASIS Survey. Diab Metab. 2010;36:476\u201383.","journal-title":"Diab Metab"},{"key":"2002_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161365.GL","volume":"22","author":"WT Garvey","year":"2016","unstructured":"Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22:1\u2013203. https:\/\/doi.org\/10.4158\/EP161365.GL.","journal-title":"Endocr Pract"},{"key":"2002_CR10","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1001\/jamainternmed.2024.4346","volume":"184","author":"TA Wadden","year":"2024","unstructured":"Wadden TA, Brown GK, Egebjerg C, Frenkel O, Goldman B, Kushner RF, et al. Psychiatric safety of semaglutide for weight management in people without known major psychopathology: post hoc analysis of the STEP 1, 2, 3, and 5 trials. JAMA Intern Med. 2024;184:1290\u20131300. https:\/\/doi.org\/10.1001\/jamainternmed.2024.4346.","journal-title":"JAMA Intern Med"},{"key":"2002_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75965-2","volume":"14","author":"E Kornelius","year":"2024","unstructured":"Kornelius E, Huang JY, Lo SC, Huang CN, Yang YS. The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy. Sci Rep. 2024;14:24433. https:\/\/doi.org\/10.1038\/s41598-024-75965-2.","journal-title":"Sci Rep"},{"key":"2002_CR12","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1001\/jamainternmed.2024.4369","volume":"184","author":"P Ueda","year":"2024","unstructured":"Ueda P, S\u00f6derling J, Wintzell V, Svanstr\u00f6m H, Pazzagli L, Eliasson B, et al. GLP-1 receptor agonist use and risk of suicide death. JAMA Intern Med. 2024;184:1301\u201312. https:\/\/doi.org\/10.1001\/jamainternmed.2024.4369.","journal-title":"JAMA Intern Med"},{"key":"2002_CR13","unstructured":"Obesity and Mental Health \u2013 Scotland. 2019. https:\/\/www.obesityactionscotland.org\/media\/iyeoaxyl\/obesity-and-mental-health-final-report-with-cover.pdf."},{"key":"2002_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-2850.2008.00106.x","volume":"15","author":"S Markowitz","year":"2008","unstructured":"Markowitz S, Friedman MA, Arent SM. Understanding the relation between obesity and depression: causal mechanisms and implications for treatment. Clin Psychol Sci Pract. 2008;15:1\u201320. https:\/\/doi.org\/10.1111\/j.1468-2850.2008.00106.x.","journal-title":"Clin Psychol Sci Pract"},{"key":"2002_CR15","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/ije\/dyy223","volume":"48","author":"J Tyrrell","year":"2019","unstructured":"Tyrrell J, Mulugeta A, Wood AR, Zhou A, Beaumont RN, Tuke MA, et al. Using genetics to understand the causal influence of higher BMI on depression. Int J Epidemiol. 2019;48:834\u2013848.","journal-title":"Int J Epidemiol"},{"key":"2002_CR16","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1601-183X.2012.00846.x","volume":"11","author":"M Jokela","year":"2012","unstructured":"Jokela M, et al. Body mass index and depressive symptoms: instrumental-variables regression with genetic risk score. Genes Brain Behav. 2012;11:942\u2013948. https:\/\/doi.org\/10.1111\/j.1601-183X.2012.00846.x.","journal-title":"Genes Brain Behav"},{"key":"2002_CR17","doi-asserted-by":"publisher","first-page":"32730","DOI":"10.1038\/srep32730","volume":"6","author":"FP Hartwig","year":"2016","unstructured":"Hartwig FP, Bowden J, Loret de Mola C, Tovo-Rodrigues L, Davey Smith G, Horta BL. Body mass index and psychiatric disorders: a Mendelian randomization study. Sci Rep. 2016;6:32730. https:\/\/doi.org\/10.1038\/srep32730.","journal-title":"Sci Rep"},{"key":"2002_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ajmg.b.32286","volume":"168B","author":"S Walter","year":"2015","unstructured":"Walter S, Kubzansky LD, Koenen KC, Liang L, Tchetgen Tchetgen EJ, Cornelis MC, et al. Revisiting Mendelian randomization studies of the effect of body mass index on depression. Am J Med Genet B Neuropsychiatr Genet. 2015;168B:108\u201315.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"2002_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1192\/bjp.bp.113.130419","volume":"205","author":"CF Hung","year":"2014","unstructured":"Hung CF, Rivera M, Craddock N, Owen MJ, Gill M, Korszun A. Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study. Br J Psychiatry. 2014;205:24\u20138.","journal-title":"Br J Psychiatry"},{"key":"2002_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1365-2796.2011.02357.x","volume":"269","author":"M Kivim\u00e4ki","year":"2011","unstructured":"Kivim\u00e4ki M, Jokela M, Batty GD. Does obesity really protect against psychological distress? Examining the \u2018fat-jolly\u2019 versus \u2018fat-sad\u2019 hypotheses using Mendelian randomization. J Intern Med. 2011;269:519.","journal-title":"J Intern Med"},{"key":"2002_CR21","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1399-5618.2010.00855.x","volume":"12","author":"DJ Bond","year":"2010","unstructured":"Bond DJ, Kunz M, Torres IJ, Lam RW, Yatham LN. The association of weight gain with mood symptoms and functional outcomes following a first manic episode: prospective 12- month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). Bipolar Disord. 2010;12:616\u201326. https:\/\/doi.org\/10.1111\/j.1399-5618.2010.00855.x.","journal-title":"Bipolar Disord"},{"key":"2002_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jad.2016.10.010","volume":"208","author":"M Buoli","year":"2017","unstructured":"Buoli M, Dell'Osso B, Caldiroli A, Carnevali GS, Serati M, Suppes T, et al. Obesity and obstetric complications are associated with rapid-cycling in Italian patients with bipolar disorder. J Affect Disord. 2017;208:278\u2013283. https:\/\/doi.org\/10.1016\/j.jad.2016.10.010.","journal-title":"J Affect Disord"},{"key":"2002_CR23","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.4088\/JCP.13m08795","volume":"75","author":"P Manu","year":"2014","unstructured":"Manu P, Khan S, Radhakrishnan R, Russ MJ, Kane JM, Correll CU. Body mass index identified as an independent predictor of psychiatric readmission. J Clin Psychiatry. 2014;75:e573\u2013577. https:\/\/doi.org\/10.4088\/JCP.13m08795.","journal-title":"J Clin Psychiatry"},{"key":"2002_CR24","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1742-1241.2007.01416.x","volume":"61","author":"A Tschoner","year":"2007","unstructured":"Tschoner A, Engl J, Laimer M, Kaser S, Rettenbacher M, Fleischhacker WW, et al. Metabolic side effects of antipsychotic medication. Int J Clin Pr. 2007;61:1356\u201370.","journal-title":"Int J Clin Pr"},{"key":"2002_CR25","unstructured":"Francois Z, Rizvi A. Psychiatric complications of bariatric surgery. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK604208\/."},{"key":"2002_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4239\/wjd.v8.i11.464","volume":"8","author":"R Lupoli","year":"2017","unstructured":"Lupoli R, Lembo E, Saldalamacchia G, Avola CK, Angrisani L, Capaldo B. Bariatric surgery and long-term nutritional issues. World J Diab. 2017;8:464\u201374.","journal-title":"World J Diab"},{"key":"2002_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/837989","volume":"2013","author":"JF Kubik","year":"2013","unstructured":"Kubik JF, Gill RS, Laffin M, Karmali S. The impact of bariatric surgery on psychological health. J Obes. 2013;2013:837989. https:\/\/doi.org\/10.1155\/2013\/837989.","journal-title":"J Obes"},{"key":"2002_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3458","volume":"37","author":"HH Loh","year":"2021","unstructured":"Loh HH, Francis B, Lim LL, Lim QH, Yee A, Loh HS. Improvement in mood symptoms after post-bariatric surgery among people with obesity: a systematic review and meta-analysis. Diab\/Metab Res Rev. 2021;37:e3458. https:\/\/doi.org\/10.1002\/dmrr.3458.","journal-title":"Diab\/Metab Res Rev"},{"key":"2002_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13927","volume":"13","author":"AJ Budin","year":"2025","unstructured":"Budin AJ, Sumithran P, MacCormick AD, Caterson I, Brown WA. Depressive symptoms at short-, medium-, and long-term follow-up after bariatric surgical procedures: a systematic review and meta-analysis. Obes Rev. 2025;13:e13927. https:\/\/doi.org\/10.1111\/obr.13927.","journal-title":"Obes Rev"},{"key":"2002_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/oby.21322","volume":"24","author":"S Driscoll","year":"2016","unstructured":"Driscoll S, Gregory DM, Fardy JM, Twells LK. Long-term health-related quality of life in bariatric surgery patients: a systematic review and meta-analysis. Obesity. 2016;24:60\u201370. https:\/\/doi.org\/10.1002\/oby.21322.","journal-title":"Obesity"},{"key":"2002_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12290","volume":"9","author":"A Szmulewicz","year":"2019","unstructured":"Szmulewicz A, Wanis KN, Gripper A, Angriman F, Hawel J, Elnahas A, et al. Mental health quality of life after bariatric surgery: a systematic review and meta-analysis of randomized clinical trials. Clin Obes. 2019;9:e12290. https:\/\/doi.org\/10.1111\/cob.12290.","journal-title":"Clin Obes"},{"key":"2002_CR32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39638","volume":"15","author":"MM Raza","year":"2023","unstructured":"Raza MM, Njideaka-Kevin T, Polo J, Azimuddin K. Long-term outcomes of bariatric surgery: a systematic review. Cureus. 2023;15:e39638. https:\/\/doi.org\/10.7759\/cureus.39638.","journal-title":"Cureus"},{"key":"2002_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.orcp.2015.11.009","volume":"10","author":"S Jumbe","year":"2016","unstructured":"Jumbe S, Bartlett C, Jumbe SL, Meyrick J. The effectiveness of bariatric surgery on long term psychosocial quality of life - a systematic review. Obes Res Clin Pract. 2016;10:225\u201342. https:\/\/doi.org\/10.1016\/j.orcp.2015.11.009.","journal-title":"Obes Res Clin Pract"},{"key":"2002_CR34","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/oby.22769","volume":"28","author":"AM Chao","year":"2020","unstructured":"Chao AM, Wadden TA, Berkowitz RI, Blackburn G, Bolin P, Clark JM, et al. Weight change 2 Years after termination of the intensive lifestyle intervention in the look AHEAD study. Obesity. 2020;28:893\u2013901. https:\/\/doi.org\/10.1002\/oby.22769.","journal-title":"Obesity"},{"key":"2002_CR35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1161\/01.cir.0000437739.71477.ee","volume":"129","author":"MD Jensen","year":"2014","unstructured":"Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129:102\u201338.","journal-title":"Circulation"},{"key":"2002_CR36","doi-asserted-by":"crossref","unstructured":"Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Pract. 2016;22:1\u2013203.","DOI":"10.4158\/EP161365.GL"},{"key":"2002_CR37","unstructured":"National Institute of Health (NIH). The Practical Guide to the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. National Heart Lung and Blood Institute Guidelines. National Institute of Health (NIH); 2000;1\u201394. https:\/\/www.nhlbi.nih.gov\/files\/docs\/guidelines\/prctgd_c.pdf."},{"key":"2002_CR38","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1210\/jc.2014-3415","volume":"100","author":"CM Apovian","year":"2015","unstructured":"Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, et al. Endocrine S. Pharmacological management of obesity: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:342\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"2002_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.103020","volume":"79","author":"L Liu","year":"2024","unstructured":"Liu L, Li Z, Ye W, Peng P, Wang Y, Wan L, et al. Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis. EClinicalMedicine. 2024;79:103020. https:\/\/doi.org\/10.1016\/j.eclinm.2024.103020.","journal-title":"EClinicalMedicine"},{"key":"2002_CR40","doi-asserted-by":"crossref","unstructured":"Tran K et al. Bupropion for treatment-resistant depression. Canadian Agency for Drugs and Technologies in Health. 2021.","DOI":"10.51731\/cjht.2021.55"},{"key":"2002_CR41","doi-asserted-by":"publisher","first-page":"940","DOI":"10.5114\/aoms.2020.96908","volume":"17","author":"A Kulak-Bejda","year":"2020","unstructured":"Kulak-Bejda A, Bejda G, Waszkiewicz N. Safety and efficacy of naltrexone for weight loss in adult patients - a systematic review. Arch Med Sci. 2020;17:940\u201353. https:\/\/doi.org\/10.5114\/aoms.2020.96908.","journal-title":"Arch Med Sci"},{"key":"2002_CR42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.numecd.2006.10.003","volume":"18","author":"DN Kiortsis","year":"2008","unstructured":"Kiortsis DN, Tsouli S, Filippatos TD, Konitsiotis S, Elisaf MS. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study. Nutr Metab Cardiovasc Dis. 2008;18:207\u201310. https:\/\/doi.org\/10.1016\/j.numecd.2006.10.003.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2002_CR43","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.brat.2013.01.002","volume":"51","author":"CM Grilo","year":"2013","unstructured":"Grilo CM, White MA. Orlistat with behavioral weight loss for obesity with versus without binge eating disorder: randomized placebo-controlled trial at a community mental health center serving educationally and economically disadvantaged Latino\/as. Behav Res Ther. 2013;51:167\u201375. https:\/\/doi.org\/10.1016\/j.brat.2013.01.002.","journal-title":"Behav Res Ther"},{"key":"2002_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000194728","volume":"13","author":"JJ Holst","year":"1997","unstructured":"Holst JJ, Orskov C, Hartmann B, Deacon CF. Posttranslational processing of proglucagon and postsecretory fate of progluca-gon products. Front Diab. 1997;13:24\u201348. https:\/\/doi.org\/10.1159\/000194728.","journal-title":"Front Diab"},{"key":"2002_CR45","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3390\/nu13041158","volume":"13","author":"L Cifuentes","year":"2021","unstructured":"Cifuentes L, Camilleri M, Acosta A. Gastric sensory and motor functions and energy intake in health and obesity-therapeutic implications. Nutrients. 2021;13:1158. https:\/\/doi.org\/10.3390\/nu13041158.","journal-title":"Nutrients"},{"key":"2002_CR46","doi-asserted-by":"publisher","first-page":"100990","DOI":"10.1016\/j.molmet.2020.100990","volume":"37","author":"BL Panaro","year":"2020","unstructured":"Panaro BL, Yusta B, Matthews D, Koehler JA, Song Y, Sandoval DA, et al. Intestine-selectivereduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion. Mol Metab. 2020;37:100990. https:\/\/doi.org\/10.1016\/j.molmet.2020.100990.","journal-title":"Mol Metab"},{"key":"2002_CR47","unstructured":"EMA statement on ongoing review of GLP-1 receptor agonists. 2024. https:\/\/www.ema.europa.eu\/en\/news\/ema-statement-ongoing-review-glp-1-receptor-agonists."},{"key":"2002_CR48","unstructured":"FDA\u2019s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity. 2024. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/update-fdas-ongoing-evaluation-reports-suicidal-thoughts-or-actions-patients-taking-certain-type."},{"key":"2002_CR49","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/dom.16046","volume":"27","author":"KA Gudzune","year":"2025","unstructured":"Gudzune KA, Stefanski A, Cao D, Mojdami D, Wang F, Ahmad N, et al. Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: results from the SURMOUNT-1 study. Diab Obes Metab. 2025;27:539\u201350. https:\/\/doi.org\/10.1111\/dom.16046.","journal-title":"Diab Obes Metab"},{"key":"2002_CR50","doi-asserted-by":"publisher","unstructured":"Pierret ACS, Mizuno Y, Saunders P, Lim E, De Giorgi R, Howes OD, et al. Glucagon-like peptide 1 receptor agonists and mental health: a systematic review and meta-analysis. JAMA Psychiatry. 2025. https:\/\/doi.org\/10.1001\/jamapsychiatry.2025.0679.","DOI":"10.1001\/jamapsychiatry.2025.0679"},{"key":"2002_CR51","unstructured":"Breit S, Hubl D. The effect of GLP-1RAs on mental health and psychotropics-induced metabolic disorders: a systematic review."},{"key":"2002_CR52","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jpsychires.2023.05.041","volume":"164","author":"DH Cooper","year":"2023","unstructured":"Cooper DH, Ramachandra R, Ceban F, Di Vincenzo JD, Rhee TG, Mansur RB, et al. Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: a systematic review. J Psychiatr Res. 2023;164:80\u201389.","journal-title":"J Psychiatr Res"},{"key":"2002_CR53","doi-asserted-by":"publisher","first-page":"103238","DOI":"10.1016\/j.dsx.2025.103238","volume":"19","author":"R Di Stefano","year":"2025","unstructured":"Di Stefano R, Rindi LV, Baldini V, Rossi R, Pacitti F, Jannini EA, et al. Glucagon-Like Peptide-1 receptor agonists, dual GIP\/GLP-1 receptor agonist tirzepatide and suicidal ideation and behavior: A systematic review of clinical studies and pharmacovigilance reports. Diabetes Metab Syndr. 2025;19:103238. https:\/\/doi.org\/10.1016\/j.dsx.2025.103238.","journal-title":"Diabetes Metab Syndr"},{"key":"2002_CR54","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.7326\/M24-0329","volume":"177","author":"H Tang","year":"2024","unstructured":"Tang H, Lu Y, Donahoo WT, Shao H, Shi L, Fonseca VA, et al. Glucagon-like peptide-1 receptor agonists and risk for suicidal ideation and behaviors in U.S. older adults with type 2 diabetes : a target trial emulation study. Ann Intern Med. 2024;177:1004\u201315. https:\/\/doi.org\/10.7326\/M24-0329.","journal-title":"Ann Intern Med"},{"key":"2002_CR55","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jpsychires.2025.02.008","volume":"183","author":"K Valentino","year":"2025","unstructured":"Valentino K, Teopiz KM, Cheung W, Wong S, Le GH, Rosenblat JD, et al. The effect of glucagon-like Peptide-1 receptor agonists on measures of suicidality: a systematic review. J Psychiatr Res. 2025;183:112\u201326.","journal-title":"J Psychiatr Res"},{"key":"2002_CR56","doi-asserted-by":"publisher","first-page":"e2423385","DOI":"10.1001\/jamanetworkopen.2024.23385","volume":"7","author":"G Schoretsanitis","year":"2024","unstructured":"Schoretsanitis G, Weiler S, Barbui C, Raschi E, Gastaldon C. Disproportionality analysis from World Health Organization data on semaglutide, liraglutide, and suicidality. JAMA Netw Open. 2024;7:e2423385. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.23385.","journal-title":"JAMA Netw Open"},{"key":"2002_CR57","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/oby.24222","volume":"33","author":"RF Kushner","year":"2025","unstructured":"Kushner RF, Ryan DH, Deanfield J, Kokkinos A, Cercato C, Wilding J, et al. Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial. Obesity. 2025;33:452\u201362. https:\/\/doi.org\/10.1002\/oby.24222.","journal-title":"Obesity"},{"key":"2002_CR58","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamapsychiatry.2025.0091","volume":"82","author":"P Ebrahimi","year":"2025","unstructured":"Ebrahimi P, Batlle JC, Ayati A, Maqsood MH, Long C, Tarabanis C, et al. Suicide and Self-Harm Events With GLP-1 Receptor Agonists in Adults With Diabetes or Obesity: A Systematic Review and Meta-Analysis. JAMA psychiatry. 2025;82:888\u2013895. https:\/\/doi.org\/10.1001\/jamapsychiatry.2025.0091.","journal-title":"JAMA psychiatry"},{"key":"2002_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.70037","volume":"41","author":"G Bushi","year":"2025","unstructured":"Bushi G, Satapathy P, Gaidhane AM, Vadia N, Menon SV, Chennakesavulu K, et al. Association of GLP-1 receptor agonists with risk of suicidal ideation and behaviour: a systematic review and meta-analysis. Diab\/Metab Res Rev. 2025;41:e70037. https:\/\/doi.org\/10.1002\/dmrr.70037.","journal-title":"Diab\/Metab Res Rev"},{"key":"2002_CR60","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/dom.14039","volume":"22","author":"E J\u00f3dar","year":"2020","unstructured":"J\u00f3dar E, Michelsen M, Polonsky W, R\u00e9a R, Sandberg A, Vilsb\u00f8ll T, et al. Semaglutide improves health-related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6). Diabetes Obes Metab. 2020;22:1339\u20131347. https:\/\/doi.org\/10.1111\/dom.14039.","journal-title":"Diabetes Obes Metab"},{"key":"2002_CR61","unstructured":"Chen X, Zhao P, Wang W, Guo L, Pan Q. The antidepressant effects of GLP-1 receptor agonists: a systematic review and meta-analysis."},{"key":"2002_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13150","volume":"22,4","author":"RA Jones","year":"2021","unstructured":"Jones RA, Lawlor ER, Birch JM, Patel MI, Werneck AO, Hoare E, et al. The impact of adult behavioural weight management interventions on mental health: a systematic review and meta-analysis. Obes Rev. 2021;22,4:e13150. https:\/\/doi.org\/10.1111\/obr.13150.","journal-title":"Obes Rev"},{"key":"2002_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-022-02067-3","volume":"11","author":"T Bradley","year":"2022","unstructured":"Bradley T, Campbell E, Dray J, Bartlem K, Wye P, Hanly G, et al. Systematic review of lifestyle interventions to improve weight, physical activity and diet among people with a mental health condition. Syst Rev. 2022;11:198. https:\/\/doi.org\/10.1186\/s13643-022-02067-3.","journal-title":"Syst Rev"},{"key":"2002_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.orcp.2021.11.002","volume":"16","author":"R Fu","year":"2022","unstructured":"Fu R, Zhang Y, Yu K, Mao D, Su H. Bariatric surgery alleviates depression in obese patients: a systematic review and meta-analysis. Obes Res Clin Pr. 2022;16:10\u201316. https:\/\/doi.org\/10.1016\/j.orcp.2021.11.002.","journal-title":"Obes Res Clin Pr"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-02002-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-02002-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-02002-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:46:29Z","timestamp":1780317989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-02002-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2002"],"URL":"https:\/\/doi.org\/10.1038\/s41366-025-02002-1","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work, the author used Prolixity only to improve language and readability. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of AI assissted language review"}}]}}